Dr. Zainab Syed, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9299 Coral Reef Dr Ste 202, Palmetto Bay, FL 33157 Phone: 305-234-9180 Fax: 305-234-9182 |
Mrs. Shawna Marie Garito, ARNP Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 9299 Coral Reef Dr Ste 203, Palmetto Bay, FL 33157 Phone: 305-234-9180 |
Amanda Rodriguez, PA Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 9299 Coral Reef Dr Ste 202, Palmetto Bay, FL 33157 Phone: 305-234-9180 |
News Archive
A first-in-human study featured in the February issue of The Journal of Nuclear Medicine reports that the novel positron emission tomography/computed tomography tracer 18F-GP1 showed excellent image quality and a high detection rate for the diagnosis of acute venous thromboembolism.
Will adding fiber to my diet bring relief? Are dairy products really off limits? Is there a way to actually diagnose what I have, or is it all in my head?
Amorfix Life Sciences, a company focused on treatments and diagnostics for brain wasting diseases, today announced it has achieved 100% specificity (no reproducible false positive results) upon testing 10,000 blood donations for variant Creutzfeldt-Jakob Disease ("vCJD"). with the EP-vCJD(TM) Blood Screening Assay at l'Etablissement Français du Sang de Pyrénées Méditerrannée ("EFS-PM") in Montpellier, France.
The Heart and Stroke Foundation calls on the federal government to live up to the commitment made two years ago to regulate trans fats in Canada's food supply, based on Health Canada's final set of monitoring results released today.
Regulus Therapeutics Inc. today announced the publication of new results in the journal Nature Biotechnology by Regulus scientists and collaborators. The new study demonstrated that systemic treatment of a microRNA therapeutic targeting microRNA-10b in tumor-bearing mice inhibits breast cancer metastasis. Cancer-related metastasis is a major cause of mortality and current cancer treatments have limited utility suppressing the metastatic spread of cancer cells. microRNA therapeutics targeting miR-10b represent a promising approach for the discovery and development of a novel anti-metastatic agent.
› Verified 1 days ago